It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

More Americans are using small solar panels in their back yards or balconies as a clean way to cut their electric bills If you feel like your electricity bill just keeps climbing, you aren’t imagining ...

The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...

2:14 New Brunswick government’s response to NB Power review The New Brunswick government says it will make sweeping changes to its debt-saddled public power utility — but would not commit to avoiding ...

Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and ...

The case for—and against—digital employees by Mike Seymour, Dan Lovallo, Kai Riemer, Alan R. Dennis and Lingyao (Ivy) Yuan All companies want to give their customers richer and more engaging ...

Before the rise of generative AI tools, fixing a batch of images would be messy business. It would mean bouncing between three browser tabs, logging into tools you had forgotten you had an account on, ...

Learn the common mistakes of using one Apple Account on multiple iPhones, including iCloud syncing, Messages, FaceTime, Find My, and security risks. Using the same Apple Account on multiple iPhones ...

That beloved wooden spoon and trusty sponge have more in common than you think: they both need to go sooner than you're replacing them. Pamela is a freelance food and travel writer based in Astoria, ...

Donald Trump's Fed chair nominee is basically using "common core" math to deceive the president, according to an ex-insider. Marjorie Taylor Greene, the former Georgia congresswoman who lost her seat ...

Neoadjuvant intralesional daromun (L19IL2/L19TNF) in resectable locally advanced melanoma: An update on the primary outcome and sensitivity analyses (EFS) from the PIVOTAL phase 3 trial. Late-stage ...